ALDERLEY PARK, UK - TheraCryf plc (AIM: TCF), a clinical stage biopharmaceutical company specializing in oncology and neuropsychiatry, announced today the appointment of Dr Alastair Smith as its ...
Alderley Park, UK - 19 February 2025: TheraCryf plc (AIM: TCF), the clinical stage drug development company focussing on oncology and neuropsychiatry has appointed Dr Alastair Smith as Non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback